Business Context and Reporting Period
XWELL, Inc. (XWEL) filed a Current Report on Form 8-K on November 3, 2025, regarding a material definitive agreement entered into on the same date. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
This filing details a restructuring of existing capital rather than a standard financial performance report. Key transaction metrics include:
- Exchange Value: Investors exchanged Series G Preferred Stock with an aggregate Stated Value of $1,553,806.00 (including accrued dividends).
- New Debt Issuance: The Company issued senior secured convertible notes with an aggregate principal amount of $3,387,138.80.
- Interest Rate: Notes bear 8.0% interest per annum, compounded quarterly, increasing to 15% upon an Event of Default.
- Liquidity Covenants: The Company must maintain at least $1,000,000 in unencumbered cash and deposit $1,350,000 into a segregated account.
- Conversion Terms: Initial conversion price for Notes, Series G Preferred Stock, and Warrants reduced to $1.00 per share.
Material Changes Versus Prior Period
The filing represents a significant modification of the capital structure established in a January 14, 2025, Private Placement. Material changes include:
- Debt Restructuring: Conversion of a portion of equity (Series G Preferred Stock) into senior secured debt.
- Price Adjustments: Reduction of the Series G Conversion Price from $1.496 to $1.00 and Warrant exercise prices from $1.496/$1.7952 to $1.00.
- Covenant Relief: Removal of the restrictive covenant requiring the Company to maintain cash equal to 200% of shares issuable upon conversion of Series G Preferred Stock.
- Anti-Dilution Provisions: Addition of price-based anti-dilution adjustments for both the Notes and the remaining Series G Preferred Stock.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook: The Company expects the exchange to close on or about November 5, 2025. The Company is required to hold a stockholder meeting by December 31, 2025, to approve the issuance of shares upon conversion of the Notes (exceeding 19.99% of outstanding shares) and the amended terms.
Risks and Contingencies:
- Stockholder Approval: Issuance of shares upon conversion is limited until stockholder approval is obtained.
- Benefit Ownership Limits: Holders are generally prohibited from converting if it results in ownership exceeding 4.99% of outstanding common stock (adjustable to 9.99% with notice).
- Default Risk: Events of default include suspension of trading or failure to pay amounts due, triggering a 15% interest rate.
- Make-Whole Payments: Holders are entitled to make-whole payments upon conversion or redemption, calculated as additional interest that would have accrued through the maturity date.
Important Facts for Investor Verification
- Verify the closing of the exchange on or about November 5, 2025.
- Confirm the scheduling and outcome of the stockholder meeting required by December 31, 2025.
- Monitor the Company's ability to maintain the $1,000,000 unrestricted cash covenant and the $1,350,000 segregated deposit.
- Review the full text of the Securities Exchange and Amendment Agreement (Exhibit 10.1) for specific limitations on share issuance.
- Track the impact of the $1.00 conversion price on potential future dilution.